Difference between revisions of "Part:BBa I751502"
m
 
(2 intermediate revisions by the same user not shown)
Line 13: Line 13:
 
===Usage and Biology===
 
===Usage and Biology===
  
−
The characteristics of this hybrid promoter (Lux-lac hybrid promoter) have been determined though [http://parts.mit.edu/igem07/index.php/Tokyo/Works/Assay0| Assay 0]. The results are shown in Fig.1.
+
The characteristics of this hybrid promoter (Lux-lac hybrid promoter) have been determined though [http://2007.igem.org/Tokyo/Works/Assay0 Assay 0]. The results are shown in Fig.1.
 
'''The newly devised hybrid promoter is activated by AHL and repressed by LacI.'''
 
'''The newly devised hybrid promoter is activated by AHL and repressed by LacI.'''
 
<br>In the present project, this hybrid promoter has been tested on the [[Part:BBa_I751100|BBa_I751100. (J54140del Pr)]]
 
<br>In the present project, this hybrid promoter has been tested on the [[Part:BBa_I751100|BBa_I751100. (J54140del Pr)]]
Line 31: Line 31:
 
===Functional Parameters===
 
===Functional Parameters===
 
<partinfo>BBa_I751501 parameters</partinfo>
 
<partinfo>BBa_I751501 parameters</partinfo>
−
see [http://parts.mit.edu/igem07/index.php/Tokyo/Hill_function_fitting| details]
+
see [http://2007.igem.org/Tokyo/Hill_function_fitting details]
  
 
== [[Tokyo/AHL assay|1.AHL assay]] ==
 
== [[Tokyo/AHL assay|1.AHL assay]] ==
Line 43: Line 43:
  
 
<br>
 
<br>
−
====⇒see more [http://parts.mit.edu/igem07/index.php/Tokyo/AHL_assay| details]====
+
====⇒see more [http://2007.igem.org/Tokyo/AHL_assay details]====
  
 
== [[Tokyo/IPTG assay|2.IPTG assay]] ==
 
== [[Tokyo/IPTG assay|2.IPTG assay]] ==
Line 56: Line 56:
 
The concentration of IPTG dose-denpendently increased GFP fluorescence. It indicates that the hybrid promoter in the cells expressing LacI became increasingly strengthened by decline of repression by LacI. The activation graph in Fig. 3, the characteristics of the hybrid promoter expressed in Hill function is determined.  
 
The concentration of IPTG dose-denpendently increased GFP fluorescence. It indicates that the hybrid promoter in the cells expressing LacI became increasingly strengthened by decline of repression by LacI. The activation graph in Fig. 3, the characteristics of the hybrid promoter expressed in Hill function is determined.  
 
<br>
 
<br>
−
====⇒see more [http://parts.mit.edu/igem07/index.php/Tokyo/IPTG_assay| details]====
+
====⇒see more [http://2007.igem.org/Tokyo/IPTG_assay details]====
 
<br><br>
 
<br><br>
  
Line 64: Line 64:
 
<br>'''n3 = 2.47 (-)'''
 
<br>'''n3 = 2.47 (-)'''
 
<br>'''K3 = 0.295 (μM)'''
 
<br>'''K3 = 0.295 (μM)'''
−
<br>see [http://parts.mit.edu/igem07/index.php/Tokyo/Hill_function_fitting| formulations]
+
<br>see [http://2007.igem.org/Tokyo/Hill_function_fitting formulations]
  
  
 
<!-- -->
 
<!-- -->

Latest revision as of 23:20, 26 October 2007

plux-lac hybrid promoter

sense TWO INPUTS, activation by AHL and repression by LacI.

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]

Usage and Biology

The characteristics of this hybrid promoter (Lux-lac hybrid promoter) have been determined though [http://2007.igem.org/Tokyo/Works/Assay0 Assay 0]. The results are shown in Fig.1. The newly devised hybrid promoter is activated by AHL and repressed by LacI.
In the present project, this hybrid promoter has been tested on the BBa_I751100. (J54140del Pr)


Fig.1: The result of assay0
Only in the presence of AHL and in the absence of lacI, the lux lac hybrid promoter is activated significantly.













Functional Parameters

negative_regulators1
positive_regulators1

see [http://2007.igem.org/Tokyo/Hill_function_fitting details]

1.AHL assay


Fig. 2 Effect of AHL on hybrid promoter Enhanced fluorescence intensity represents up-regulation of LuxR via AHL.

Purpose
check how AHL activates lux-lac hybrid promoter.
These parameters(n2,K2) is decided.

Result & Conclusion
As the concentration of AHL increases, GFP fluorescence increased, indicating that the hybrid promoter’s activation is strengthend with increasing concentration of AHL. From the activation graph in Fig. 2, the characteristics of the hybrid promoter expressed in Hill function, such as (n2,K2), is determined.


⇒see more [http://2007.igem.org/Tokyo/AHL_assay details]

2.IPTG assay

Fig. 3 Effect of LacI on hybrid promoter Enhanced fluorescence intensity represents down-regulation of LacI repression via IPTG.

Purpose
check how LacI represses this hybrid promoter. In order to adjust LacI repression, IPTG was added.
These parameters(n3,K3) is decided.

Result & Conclusion
The concentration of IPTG dose-denpendently increased GFP fluorescence. It indicates that the hybrid promoter in the cells expressing LacI became increasingly strengthened by decline of repression by LacI. The activation graph in Fig. 3, the characteristics of the hybrid promoter expressed in Hill function is determined.

⇒see more [http://2007.igem.org/Tokyo/IPTG_assay details]



We have determined Hill coefficients, coefficients of repression and activation of AHL and LacI（n2,n3,k2,k3) as follows.
n2 = 2.08 (-)
K2 = 4.05 (μM)
n3 = 2.47 (-)
K3 = 0.295 (μM)
see [http://2007.igem.org/Tokyo/Hill_function_fitting formulations]